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AnticancerAbstract A mild and efﬁcient cyclization procedure for the synthesis of (E)-80-arylidene-50,60,70,80-
tetrahydrospiro[oxindole-3,40-pyrano[3,2-c]pyridin] derivatives was achieved via one-pot three-com-
ponent condensation of isatins, malononitrile and (E)-3-arylidene-1-methylpiperidin-4-ones using
piperidine as an efﬁcient catalyst and ethanol as an environmentally benign solvent. The in vitro
antitumor activity of these compounds was evaluated in human cervical carcinoma cell line (Hela),
human liver hepatocellular carcinoma cell line (HepG2), and human breast carcinoma cell line
(MDA-MB-231).
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
As a well-known and signiﬁcant structural constituent, the
heterocyclic spirooxindole ring skeleton presents in a number
of natural products (Cui et al., 1996; Williams and Cox, 2003)
and other useful compounds. There are numerous spirooxindoleheterocycles; especially, these compounds containing a spiroox-
indole fused with a monoarylidenepiperidin-4-one ring system
possess a variety of highly pronounced biological activity and
potential medicinal applications, such as antibacterial activity
(Dandia et al., 2013), antimycobacterial activity (Kumar et al.,
2008), antitubercular activity (Karthikeyan et al., 2010), anti-
tumor activity (Girgis, 2009), and cholinesterase inhibitory
activity (Kia et al., 2014a,b). The signiﬁcance in biological activ-
ity may be creditable to their unique structural characteristics,
whose structural frameworks assemble two important bioactive
heterocycle moieties into a single molecule. To complete the
merger of spirooxindole and monoarylidenepiperidin-4-one,
intense efforts have been made for the development of various
efﬁcient methods during the past few years, and almost all ofano[3,2-
2 D.-C. Wang et al.them are based on 1,3-dipolar cycloaddition reaction (Kumar
and Perumal, 2007). Despite these remarkable advances, ﬁnding
cost-effective, sustainable and creative synthetic methods to
reproduce the structural diversity and complexity of biologically
important spirooxindole fused with a monoarylidenepiperidin-
4-one skeleton would always be a welcome addition, including
the design of novel substrate and methodology itself. Accord-
ingly, we make an attempt at accomplishing above-mentioned
goal employing another strategy as a candidate reference
method, which utilizes a one-pot reaction combining several
transformations including preliminary Knoevenagel condensa-
tion (Chakrabarty et al., 2009), further addition and ﬁnal intra-
molecular cyclization (Chen et al., 2010). If this idea is viable,
many novel and diverse (E)-80-arylidene-50,60,70,80-tetrahydro-
spiro[oxindole-3,40-pyrano[3,2-c]pyridin] derivatives will be
formed by using different monoarylidenepiperidin-4-ones,
which can be used to identify potential drug candidates.
Recently, this strategy has been successfully applied to the
synthesis of structurally complex and diverse heterocyclic
products (Liu et al., 2013). To develop more creative methods,
the endeavor was centered on the design of new substrates
especially novel nucleophiles for further domino transforma-
tion of Knoevenagel products, including 1,3-dicarbonyl com-
pounds (Ghahremanzadeh et al., 2010; Karmakar et al.,
2012), a-methylenecarbonyl compounds (Elinson et al., 2009;
Kamalraja et al., 2014), aromatic phenolic (Heravi et al.,
2012; Park et al., 2013), dialkyl acetylenedicarboxylates
(Tisseh et al., 2012), and others. The design and synthesis of
novel nucleophiles and their use in Multicomponent reactions
(MCR) to achieve skeletal diversity might signiﬁcantly contrib-
ute in populating the chemical space. As newly emerged
nucleophiles, (E)-3-arylidene-1-methylpiperidin-4-ones were
generated in the reaction from the assembly of 1-methylpiperi-
din-4-one and aldehydes in a Mannich-elimination sequence
(Gu et al., 2014). Compared with cyclohexanone (Abdel-
Latif and Shaker, 1991; Shanthi et al., 2007), (E)-3-arylidene-
1-methylpiperidin-4-ones only have one highly selective and
active methylene as reactive site, which was conducive to
improve the reaction selectivity and yields. Under the same
condition, a comparison between the three-component
reaction of isatin, malononitrile, 1-methylpiperidin-4-one
and the three-component reaction of isatin, malononitrile,Scheme 1 A comparison between 1-methylpiper
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was shown in Scheme 1, and the structure characterization of
related compounds was shown in Fig. 1. Besides, a signiﬁcant
exocyclic monoarylidene group was embedded in novel molec-
ular structure.
Efﬁciency, sustainability and green operations are of great
importance and a demanding challenge in chemical produc-
tion. Multicomponent reactions (MCR) emerged and offered
signiﬁcant advantages, such as enhancement of atom and
energy efﬁciency, avoidance of intermediate products,
retrenchment of effort and resources, and waste minimization
(Behr et al., 2014; Khabazzadeh et al., 2012; Mosaddegh and
Hassankhani, 2012). As part of our continuing interest in the
development of novel synthetic methods in polycyclic
heterocycles, we report a mild and efﬁcient three-component
cyclization reaction of isatins, malononitrile and (E)-
3-arylidene-1-methylpiperidin-4-ones for the synthesis of novel
(E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxindole-3,40-pyrano
[3,2-c]pyridin] derivatives, using piperidine as an efﬁcient
catalyst and ethanol as an environmentally benign solvent at
ambient temperature. The in vitro antitumor activity of the
synthesized compounds was evaluated according to the
National Cancer Institute (NCI) in vitro disease-oriented
human cells screening panel assay.
2. Experimental
2.1. Reagents and analysis
All reagents were purchased from commercial sources and
used as supplied. All reactions were monitored by thin layer
chromatography (TLC silica gel 60 F254 plates), visualizing
with ultraviolet light. Melting points were measured on an
YRT-3 melting point measuring apparatus (Precision
Instrument Plant, Tianjin University) and uncorrected. The
1H NMR spectra and 13C NMR spectra were recorded using
a Bruker AM400 NMR spectrometer and the chemical shifts
in ppm were reported relative to tetramethylsilane (TMS) or
residual solvent peaks. Mass spectrometry (ESI-MS) data were
measured by a Bruker Daltonics amaZon SL mass spectrome-
ter. High-resolution mass spectrometry (HRMS) data of the
synthesized compounds were recorded by using a Waters Q-idin-4-one and monoarylidenepiperidin-4-one.
ynthesis of (E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxindole-3,40-pyrano[3,2-
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Figure 1 The structure characterization of compounds 5a, 5b, 5c.
Synthesis of (E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxindole-3,40-pyrano[3,2-c]pyridin] derivatives 3Tof premier mass spectrometer. Crystal data of 4a were col-
lected using a Xcalibur E diffractometer with monochromated
Mo Ka radiation (k= 0.71073 A˚) at 143 K, and operating in
the x scan mode. The structure was solved with the Superﬂip
structure solution program using Charge Flipping and reﬁned
with the SHELXL reﬁnement package using Least Squares
minimization. Crystallographic data (excluding structure
factors) for the structures in this paper have been deposited
with the Cambridge Crystallographic Data Centre as supple-
mentary publication Nos. CCDC 1008386, CCDC 1039039,
CCDC 1039040, CCDC 1039041. Copies of the data can be
obtained, free of charge, on application to CCDC, 12 Union
Road, Cambridge CB2 1EZ, UK, (fax: +44 (0)1223 336033
or e-mail: deposit@ccdc.cam.ac.Uk).2.2. General procedure
A solution of isatins (0.2 mmol), malononitrile (0.2 mmol) and
monoarylidene cyclic ketones (0.2 mmol) in 2 mL ethanol was
previously stirred for approximately 3 min, and then piperidine
(0.2 mmol) was added to the reaction mixture and stirred for
another 2 h with the precipitation of solid. The whole reaction
was carried out under ambient condition without applying
extra activation energy. After the completion of the reaction,
ethanol was evaporated and the obtained crude product was
puriﬁed by column chromatography (200–300 mesh silica gel,
Qingdao Marine Chemical Ltd., Qingdao, China), using petro-
leum ether/ethyl acetate/triethylamine (10:20:1, v/v/v) as elu-
ent. Further puriﬁcation of the products was accomplished
by recrystallization from ethanol. Physical and chemical data
of chosen products are as follows:
(E)-20-amino-60-methyl-2-oxo-80-(4-(triﬂuoromethyl)benzyl-
idene)-50,60,70,80-tetrahydrospiro[indoline-3,40-pyrano[3,2-c]
pyridine]-30-carbonitrile (4a): White solid; Mp 232–235 C; 1H
NMR (400 MHz, DMSO-d6): d 2.09 (s, 3H, N–CH3),
2.40–2.44 (m, 1H), 2.60–2.64 (m, 1H), 3.41–3.49 (m, 2H),
6.88–6.90 (m, 1H), 7.05–7.08 (m, 2H), 7.18–7.20 (m, 3H),
7.25–7.29 (m, 1H), 7.50 (d, J= 8 Hz, 2H), 7.77 (d,
J= 8 Hz, 2H), 10.64 (s, 1H, NH); 13C NMR (100 MHz,
DMSO-d6): d 44.2, 51.1, 51.7, 53.8, 54.1, 109.9, 110.6, 118.4,
121.1, 122.6, 124.7, 125.4, 129.3, 129.7, 131.7, 139.9, 140.9,
141.7, 160.6, 177.5. MS (ESI): m/z 465.2 [M+ H]+. HRMS
(ESI): m/z calcd for C25H19F3N4O2 + H
+: 465.1538
[M+H+]; found: 465.1531.Please cite this article in press as: Wang, D.-C. et al., Eﬃcient and mild one-pot s
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benzylidene)-50,60,70,80-tetrahydrospiro[indoline-3,40-pyrano[3,
2-c]pyridine]-30-carboxylate (4e): Pale yellow solid; Mp
268–270 C; 1H NMR (400 MHz, DMSO-d6): d 0.78 (t,
J= 7.2 Hz, 3H, CH3), 2.11 (s, 3H, N–CH3), 2.38–2.42 (m,
1H), 2.76–2.80 (m, 1H), 3.45–3.49 (m, 2H), 3.68–3.81 (m,
2H), 6.84–6.86 (m, 1H), 6.96–7.24 (m, 4H), 7.55 (d,
J= 8 Hz, 2H), 7.81 (d, J= 8 Hz, 2H), 7.86 (s, 2H), 10.46 (s,
1H, NH); 13C NMR (100 MHz, DMSO-d6): d 13.2, 44.3,
50.8, 51.2, 53.9, 58.5, 73.2, 108.9, 112.7, 120.7, 121.8, 123.1,
125.3, 125.4, 127.5, 127.9, 129.3, 129.6, 135.2, 139.3, 142.3,
160.6, 167.5, 179.3. MS (ESI): m/z 512.2 [M + H]+. HRMS
(ESI): m/z calcd for C27H24F3N3O4 + H
+: 512.1797
[M+H+]; found: 512.1783.
(E)-2-amino-20-oxo-8-(4-(triﬂuoromethyl)benzylidene)-5,6,
7,8-tetrahydrospiro[chromene-4,30-indoline]-3-carbonitrile (4p):
White solid; Mp 255–258 C; 1H NMR (400 MHz, DMSO-d6):
d 1.46–1.53 (m, 2H), 2.59–2.60 (m, 2H), 3.41–3.48 (m, 2H),
6.87–6.89 (m, 1H), 7.02–7.16 (m, 5H), 7.23–7.27 (m, 1H),
7.55 (d, J= 8 Hz, 2H), 7.75 (d, J= 8 Hz, 2H), 10.62 (s, 1H,
NH); 13C NMR (100 MHz, DMSO-d6): d 21.5, 23.6, 26.4,
52.5, 53.8, 109.8, 113.0, 118.6, 121.7, 122.6, 124.5, 125.2,
125.6, 129.0, 129.7, 131.3, 132.6, 141.8, 142.1, 160.5, 178.0.
MS (ESI): m/z 450.2 [M + H]+. HRMS (ESI): m/z calcd
for C25H18F3N3O2 + H
+: 450.1429 [M+H+]; found:
450.1422.
(E)-2-amino-20-oxo-7-(4-(triﬂuoromethyl)benzylidene)-6,7-
dihydro-5H-spiro[cyclopenta[b]pyran-4,30-indoline]-3-carboni-
trile (4q): Ecru solid; Mp 246–249 C; 1H NMR (400 MHz,
DMSO-d6): d 1.91–2.17 (m, 2H), 2.84–2.96 (m, 2H), 6.52 (s,
1H), 6.89–7.28 (m, 6H), 7.60 (d, J= 8 Hz, 2H), 7.71 (d,
J= 8 Hz, 2H), 10.66 (s, 1H, NH); 13C NMR (100 MHz,
DMSO-d6): d 25.4, 26.3, 51.3, 54.2, 109.9, 115.6, 118.6,
120.4, 122.5, 122.9, 124.6, 125.5, 125.6, 126.4, 126.7, 128.5,
129.2, 131.7, 139.8, 140.6, 141.5, 147.6, 161.7, 177.2. MS
(ESI): m/z 436.2 [M +H]+. HRMS (ESI): m/z calcd for
C24H16F3N3O2 + H
+: 436.1273 [M+H+]; found: 436.1256.
(E)-20-amino-2-oxo-80-(4-(triﬂuoromethyl)benzylidene)-70,
80-dihydro-50H-spiro[indoline-3,40-pyrano[4,3-b]pyran]-30-carbo-
nitrile (4r): White solid; Mp 244–246 C; 1H NMR (400 MHz,
DMSO-d6): d 3.56–3.81 (m, 2H), 4.56–4.65 (m, 2H), 6.89–6.91
(m, 1H), 7.05–7.09 (m, 2H), 7.22–7.30 (m, 4H), 7.47 (d,
J= 8 Hz, 2H), 7.77 (d, J= 8 Hz, 2H), 10.70 (s, 1H, NH);
13C NMR (100 MHz, DMSO-d6): d 50.1, 54.1, 62.9, 65.0,
110.0, 110.8, 118.2, 120.9, 122.7, 124.7, 125.4, 125.5, 127.5,ynthesis of (E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxindole-3,40-pyrano[3,2-
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Figure 2 Crystal structure of 4a methanol solvate (the solvent
molecule is disordered).
4 D.-C. Wang et al.127.9, 128.0, 129.4, 129.7, 131.2, 139.2, 140.1, 141.6, 160.6,
177.2. MS (ESI):m/z 452.4 [M+H]+. HRMS (ESI): m/z calcd
for C24H16F3N3O3 + H
+: 452. 1222 [M+H+]; found:
452.1208.
(Z)-20-amino-2-oxo-80-(4-(triﬂuoromethyl)benzylidene)-70,
80-dihydro-50H-spiro[indoline-3,40-thiopyrano[4,3-b]pyran]-30-
carbonitrile (4s): Gray solid; Mp 261–263 C; 1H NMR
(400 MHz, DMSO-d6): d 2.67–2.91 (m, 2H), 3.68–3.77
(m, 2H), 6.94–6.96 (m, 1H), 7.10–7.14 (m, 1H), 7.24–7.35 (m,
5H),7.63 (d, J= 8 Hz, 2H), 7.84 (d, J= 8 Hz, 2H), 10.74 (s,
1H, NH); 13C NMR (100 MHz, DMSO-d6): d 24.6, 26.3,
52.7, 54.1, 110.0, 111.3, 118.2, 122.7, 123.9, 124.7, 125.4,
128.1, 129.3, 129.9, 131.8, 139.9, 141.8, 142.9, 160.3, 177.4.
MS (ESI): m/z 468.3 [M + H]+. HRMS (ESI): m/z calcd
for C24H16F3N3O2S + H
+: 468.0994 [M+H+]; found:
468.1002.
3. Results and discussion
As shown in Table 1, a three-component reaction of isatin
(0.2 mmol), malononitrile (0.2 mmol) and (E)-1-methyl-3-(4-
(triﬂuoromethyl)benzylidene)piperidin-4-one (0.2 mmol) was
conducted in methanol using DBU as a catalyst at room tem-
perature. This reaction proceeded smoothly to afford the cor-
responding spiro compound 4a in 90% yield (Table 1, entry 1).
The structure and relative conﬁguration of the product 4a were
characterized by a single crystal X-ray crystallographic study
(Fig. 2), and a methanol solvate molecule was incorporated
in the crystalline structure. To increase the yield of theTable 1 Optimization of reaction conditions for compound 4a.
N
H
O
O +
CN
CN
+
O
N
CH3
CF3
1a 2a 3a
Entry Solvent Base (equiv)
1 MeOH DBU (1)
2 MeOH Piperidine (1)
3 MeOH Pyrrolidine (1)
4 MeOH DIEA (1)
5 MeOH Triethylamine (1)
6 EtOH Piperidine (1)
7 THF Piperidine (1)
8 CH3CN Piperidine (1)
9 1,4-Dioxane Piperidine (1)
10 Toluene Piperidine (1)
11 CH2Cl2 Piperidine (1)
12 EtOH Piperidine (2)
13 EtOH Piperidine (1.5)
14 EtOH Piperidine (0.5)
15 EtOH Piperidine (0.2)
a Isolated yield after puriﬁcation by column chromatography.
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idine, pyrrolidine, DIEA and triethylamine, and found that the
reaction with piperidine and pyrrolidine showed superior
results (Table 1, entries 2–3); the reaction with DIEA and tri-
ethylamine showed inferior results (Table 1, entries 4–5) in
terms of the yield compared with DBU as the catalyst. The
highest yield for product 4a was obtained when piperidine
was selected as the catalyst. Consequently, piperidine was
applied in the following tests.
To further evaluate the efﬁcacy of piperidine, a brief screen-
ing of solvents in the formation of 4a was carried out, viz.
methanol, ethanol, tetrahydrofuran, acetonitrile, 1,4-dioxane,Base
Solvent,rt
N
H
O
NH2
CN
O
NH3C
F3C
4a
Time, h Yield of 4aa (%)
1 90
2 94
2 93
5 82
5 81
2 95
2 94
2 89
2 90
2 84
2 75
2 95
2 95
2 93
2 90
ynthesis of (E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxindole-3,40-pyrano[3,2-
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Table 2 Synthesis of 20-aminospiro[indoline-3,40-pyran]-2-one derivatives.
N
R1
O
O +
R2
CN
+
O
Piperidine
EtOH
N
R1
O
NH2
R2
O
X
X
R3
1a-d 2a-b 3a-m
4a-t
R3
Entry R1 (1) R2 (2) X/R3 (3) Products Yield (%)a
1 H (1a) CN (2a) N–CH3/4-CF3C6H4 (3a) 4a 95
2 Me (1b) CN (2a) N–CH3/4-CF3C6H4 (3a) 4b 88
3 Et (1c) CN (2a) N–CH3/4-CF3C6H4 (3a) 4c 94
4 Bn (1d) CN (2a) N–CH3/4-CF3C6H4 (3a) 4d 80
5 H (1a) COOEt (2b) N–CH3/4-CF3C6H4 (3a) 4e 66
6 Me (1b) COOEt (2b) N–CH3/4-CF3C6H4 (3a) 4f 69
7 Et (1c) COOEt (2b) N–CH3/4-CF3C6H4 (3a) 4g 65
8 Bn (1d) COOEt (2b) N–CH3/4-CF3C6H4 (3a) 4h 60
9 H (1a) CN (2a) N–CH3/4-NO2C6H4 (3b) 4i 91
10 H (1a) CN (2a) N–CH3/4-tert-Butylphenyl (3c) 4j 82
11 H (1a) CN (2a) N–CH3/3,4-CH3C6H3 (3d) 4k 74
12 H (1a) CN (2a) N–CH3/3-CH3C6H4 (3e) 4l 98
13 H (1a) CN (2a) N–CH3/2-Naphthyl (3f) 4m 83
14 H (1a) CN (2a) N–CH3/2,4-Cl2C6H3 (3g) 4n 92
15 H (1a) CN (2a) N–CH3/4-FC6H4 (3h) 4o 97
16 H (1a) CN (2a) CH2/4-CF3C6H4 (3i) 4p 81
17 H (1a) CN (2a) 3jb 4q 65
18 H (1a) CN (2a) O/4-CF3C6H4 (3k) 4r 94
19 H (1a) CN (2a) S/4-CF3C6H4 (3l) 4s 93
20 H (1a) CN (2a) 3mc 4t 78
a Isolated yield after puriﬁcation by column chromatography.
b Compound 3j= (E)-2-(4-(triﬂuoromethyl)benzylidene)cyclopentanone.
c Compound 3m= (E)-7-(4-(triﬂuoromethyl)benzylidene)-1,4-dioxaspiro[4.5]decaN-8-one.
Synthesis of (E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxindole-3,40-pyrano[3,2-c]pyridin] derivatives 5toluene and dichloromethane (Table 1, entries 2, 6–11). To our
delight, all reactions proceeded well especially in ethanol lead-
ing to highest yield of 95%. Subsequently, the inﬂuence of the
amount of piperidine on the yield has been investigated, and
the outcomes displayed that 1 equivalent of piperidine was suf-
ﬁcient to complete this reaction (Table 1, entries 12–15). Lar-
ger amounts of piperidine did not improve the yields of the
reaction. From these results, we can ﬁnd that 1 equivalent of
piperidine and ethanol emerged as the optimized selection of
base-solvent combination for this model reaction.
Having optimized the conditions, we explored the substrate
scope of the reaction of isatins, nitrilo active methylene com-
ponents, and monoarylidene cyclic ketones (Table 2). The
detailed results show that the approach is compatible with a
wide variety of substrates. Firstly, incorporating different pro-
tecting groups on the N-1 of isatins was applied to the cycliza-
tion reaction (Table 2, entries 1–4). Then, malononitrile was
replaced with ethyl cyanoacetate to enrich the diversity of
nitrilo active methylene components (Table 2, entries 5–8).
Next, many (E)-3-arylidene-1-methylpiperidin-4-one bearing
different aromatic substituents were used for the three-compo-
nent reaction and all reactions had been carried out smoothly
with 74–98% isolated yields (Table 2, entries 9–15). In the end,
we investigated the reaction of other monoarylidene cyclicPlease cite this article in press as: Wang, D.-C. et al., Eﬃcient and mild one-pot s
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ﬂuoromethyl)benzylidene)piperidin-4-one to verify the scope
of the three-component one-pot reaction. As expected, these
reactions afforded good yields of corresponding spirooxindole
derivatives (Table 2, entries 16–20).
All targeted products 4a–4t were characterized by mass
spectrometry fragmentation pattern analysis, high-resolution
mass spectrometry, 1H NMR and 13C NMR spectroscopy.
For instance, the high-resolution mass spectrometry data of
compound 4a (Table 2, entry 1) displayed the peak at m/z
465.1531 representing the molecular ion (calculated mass for
C25H19F3N4O2 + H
+: 465.1538 [M+H+]). The 1H NMR
spectrum of compound 4a consisted of an N–CH3 signal
2.09 (s, 3H) and an NH resonance 10.64 (s, 1H). The signals
due to the four centrosymmetric aromatic protons were
observed around 7.49–7.78 ppm as two doublets: 7.50 (d,
J= 8 Hz, 2H) and 7.77 (d, J= 8 Hz, 2H).
A plausible mechanism for the reaction is shown in
Scheme 2. The reaction was proposed to proceed through the
activation of malononitrile by piperidine to generate a nucleo-
phile, followed by a nucleophilic addition on the C3 carbonyl
group in isatin with the generation of a, b-unsaturated nitrile.
The electron-deﬁcient a, b-unsaturated dicyano adduct is a
potent Michael acceptor for further domino transformationynthesis of (E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxindole-3,40-pyrano[3,2-
ry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.12.003
Scheme 2 Plausible mechanism for the reaction.
Table 3 In-vitro percentage growth inhibition (GI %) caused by the test compounds at dose of 20 lmol/L.
Compound Subpanel tumor cell lines (% growth inhibitory activity)
Hela HepG2 MDA-MB-231
4a 41.8 37.2 28.2
4b 11.7 6.8 3.5
4c 42.1 50.4 34.9
4d 56.2 54.1 48.1
4e 59.4 22.2 39.2
4f 41.5 6.9 11.3
4g 20.2 7.1 16.7
4h 16.5 9.2 26.9
4i 17.2 15.1 19.3
4j 3.5 20.1 4.8
4k 76.1 70.2 64.9
4l 39.1 38.7 28.2
4m 38.4 35.5 31.5
4n 28.7 25.6 22.1
4o 7.5 13.3 19.6
4p 31.2 25.9 27.2
4q 69.1 59.1 57.2
4r 48.9 40.5 42.7
4s 87.2 73.1 61.3
4t 40.3 31.2 22.3
Adriamycin 83.2 79.1 76.0
6 D.-C. Wang et al.in the presence of nucleophilic (E)-3-arylidene-1-methylpiperi-
din-4-one. The resulting intermediate undergoes subsequent
intramolecular cyclization through [1,3]-sigmatropic proton
shift of the iminopyran led to the formation of the ﬁnal spiro
compound.
The synthesized compounds were screened for their in vitro
antitumor activity in the full NCI 96 cell panel, includingPlease cite this article in press as: Wang, D.-C. et al., Eﬃcient and mild one-pot s
c]pyridin] derivatives with potential antitumor activity. Arabian Journal of Chemisthuman cervical carcinoma cell line (Hela), human liver hepato-
cellular carcinoma cell line (HepG2), and human breast carci-
noma cell line (MDA-MB-231). During the MTT assay, a
common chemotherapeutics drug adriamycin (ADM) was uti-
lized as positive control. In the protocol, all compounds were
tested at 20 lmol/L, and their percentage growth inhibition
(GI%) was shown in Table 3. The data revealed thatynthesis of (E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxindole-3,40-pyrano[3,2-
ry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.12.003
Synthesis of (E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxindole-3,40-pyrano[3,2-c]pyridin] derivatives 7compounds 4d, 4k, 4q and 4s exhibited outstanding growth
inhibitory activity against the tested subpanel tumor cell lines,
which could be used as lead structures for future derivatization
or modiﬁcation to obtain more potent antitumor agents.
4. Conclusion
In summary, an efﬁcient and mild cyclization procedure for the
synthesis of (E)-80-arylidene-50,60,70,80-tetrahydrospiro[oxin-
dole-3,40-pyrano[3,2-c]pyridin] derivatives has been identiﬁed
using piperidine as an efﬁcient catalyst and ethanol as an envi-
ronmentally benign solvent. The antitumor activity of these
compounds was evaluated in human cervical carcinoma cell line
(Hela), human liver hepatocellular carcinoma cell line (HepG2),
and human breast carcinoma cell line (MDA-MB-231).Appendix A. Supplementary material
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.arabjc.
2014.12.003.
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